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Abstract Gilles de la Tourette syndrome is a complex,
idiopathic neuropsychiatric disorder whose pathophysio-
logical mechanisms have yet to be elucidated. It is phe-
notypically heterogeneous and manifests more often than
not with both motor and behavioral impairment, although
tics are its clinical hallmark. Tics themselves present with a
complex profile as they characteristically wax and wane
and are often preceded by premonitory somatosensory
sensations to which it is said a tic is the response. Highly
comorbid with obsessive–compulsive disorder and atten-
tion deficit-hyperactivity disorder, it is purported to be an
epigenetic, neurodevelopmental spectrum disorder with a
complex genetic profile. It has a childhood onset, occurs
disproportionately in males, and shows spontaneous
symptomatic attenuation by adulthood in the majority of
those afflicted. Although not fully understood, its neuro-
biological basis is linked to dysfunction in the cortico-basal
ganglia–thalamo–cortical network. Treatment modalities
for Tourette syndrome include behavioral, pharmacological
and surgical interventions, but there is presently no cure for
the disorder. For those severely affected, deep brain stim-
ulation (DBS) has recently become a viable therapeutic
option. A key factor to attaining optimal results from this
surgery is target selection, a topic still under debate due to
the complex clinical profile presented by GTS patients.
Depending on its phenotypic expression and the most
problematic aspect of the disorder for the individual, one of
three brain regions is most commonly chosen for stimula-
tion: the thalamus, globus pallidus, or nucleus accumbens.
Neurophysiological analyses of intra- and post-operative
human electrophysiological recordings from clinical DBS
studies suggest a link between tic behavior and activity in
both the thalamus and globus pallidus. In particular,
chronic recordings from the thalamus have shown a cor-
relation between symptomatology and (1) spectral activity
in gamma band power and (2) theta/gamma cross fre-
quency coherence. These results suggest gamma oscilla-
tions and theta/gamma cross correlation dynamics may
serve as biomarkers for dysfunction. While acute and
chronic recordings from human subjects undergoing DBS
have provided better insight into tic genesis and the neu-
ropathophysiological mechanisms underlying Tourette
syndrome, these studies are still sparse and the field would
greatly benefit from further investigations. This review
reports data and discoveries of scientific and clinical rele-
vance from a wide variety of methods and provides up-to-
date information about our current understanding of the
pathomechanisms underlying Tourette syndrome. It gives a
comprehensive overview of the current state of knowledge
and addresses open questions in the field.
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Introduction
Gilles de la Tourette syndrome (GTS) is a complex neu-
rological disorder of unknown etiology affecting approxi-
mately 1 % of the population (Robertson 2008; American
Psychiatric Association 2013). Although it is most readily
associated with sudden outbursts of socially inappropriate
locutions, it is a neuropsychiatric disorder consisting of
considerable motor as well as behavioral impairment.
Diagnosis is determined by the childhood onset of multiple
motor tics and at least one phonic tic (not necessarily
present concurrently), which collectively must persist for at
least one cumulative year and are not precipitated by
known medical causes or pharmacological agents
(Robertson 2000; American Psychiatric Association 2013).
Symptoms typically occur at a mean onset age of about
4–7 years old, peak in severity prepubertally at about
10–12 years old, and remit or become subclinical in two-
thirds to three-fourths of the patient population by adulthood
(Freeman et al. 2000; Leckman 2002; Bloch and Leckman
2009; Leckman et al. 2010; Felling and Singer 2011). Con-
sistently, GTS has a reported four to five fold higher incidence
in children than adults (Robertson 2000; Burd et al. 2005;
Hariz and Robertson 2010). This decline in symptomatology
during maturation supports the theory that GTS is a neu-
rodevelopmental disorder in which certain brain structures
and/or processes must yet mature for proper brain function
(Kurlan et al. 2002; Ghanizadeh and Mosallaei 2009).
At approximately 10 years of age premonitory urges are
typically expressed, coincident with first observations of tic
suppression (Cohen and Leckman 1992; Kwak et al. 2003;
Leckman et al. 2010; McNaught and Mink 2011). These
sensations—which are frequently more distressful than the
tics themselves—are anatomically localized to the region
associated with the impending tic and precede the need for
action; thus, they appear to signal the oncoming tic, making
its suppression possible (Cohen and Leckman 1992;
Leckman et al. 1993). Tic expression in GTS has been
compared to sneezing: one feels the sensation coming on,
could suppress it if necessary, but feels relief once
expressed. The caveat here is that suppression of the tic is
(1) transitory and (2) often results in an increased rebound
severity of expression post-suppression (Leckman 2003;
Grados and Mathews 2009). As they are unique to tic
disorders and Tourette syndrome, the presence of pre-
monitory sensations can be used to distinguish GTS from
other movement disorders (McNaught and Mink 2011).
Tics are sudden, repetitive and purposeless and can be
either motor or phonic1 and classified as either simple or
complex. Simple tics, whether brief and jerk-like or slow
and sustained, appear meaningless, while complex tics
involve the coordination of multiple muscle groups and
may or may not appear purposeful (Jankovic and Stone
1991). Simple motor tics involve one muscle group and can
be tonic ([500 ms), dystonic ([300 ms), and/or clonic
(\100 ms) (Jankovic 1997). Simple tonic tics are exem-
plified by isometric contractions such as tensing of the
abdominal muscles, dystonic tics include shoulder rotation
and oculogyric deviation, and clonic tics are rapid move-
ments such as eye blinking, facial twitching, and head,
neck, or limb jerking (Jankovic and Stone 1991; Jankovic
2001). Simple phonic tics commonly include throat clear-
ing, coughing, or grunting. In contrast to simple tics,
complex tics involve several muscle groups and can appear
either intentional or unintentional. They consist of coor-
dinated movements such as gesturing, hopping, and body
jerking. Phonically, they may be expressed as humming,
animal sounds, and coprolalia (the uncontrollable outburst
of obscenities or socially inappropriate utterances).
Interestingly, although coprolalia is the behavior most
readily associated with Tourette syndrome, it is both not
specific to it and not present in the majority of patients.
Time of onset for this symptom has been reported at 2.2,
*4, and 5 years after tic onset and usually presents by age
fifteen (Goldenberg et al. 1994; Robertson 2000; Freeman
et al. 2009; Fahn et al. 2011; McNaught and Mink 2011). A
longitudinal study, which followed 61 patients from first
onset of symptoms to most recent medical visit in those
who had a minimum of 4 years (and an average of 8 years)
between symptom expression and physician visit, reported
9.8 % exhibited coprolalia. Nonetheless, although typically
cited at 10 %, prevalence estimates vary from 4 % to
greater than 30 % of the patient population, with discrep-
ancies attributed to cultural differences; disease severity;
gender; and age incongruities. As with other symptoms of
GTS, this one increases and then declines with age, peak-
ing in adolescence (Goetz et al. 1992; Goldenberg et al.
1994).
An overwhelming majority of GTS patients present with
comorbidities, which are most commonly comprised of
attention deficit-hyperactivity disorder (ADHD) and
obsessive–compulsive disorder (OCD) (at a frequency of
up to 80 % each), but also include anxiety (49 %), learning
disabilities (47 %), depression (25 %), and behavioral
problems (26 %), as well as self-injurious behavior and
reduced executive function, among others (Baron-Cohen
et al. 1999; Coffey et al. 2000; Robertson 2000; Kurlan
et al. 2002; Burd et al. 2005; Robertson and Orth 2006;
Freeman 2007; Roessner et al. 2007; Ghanizadeh and
Mosallaei 2009; Hariz and Robertson 2010). Symptom
severity is reported to be positively correlated with
comorbidity rates (Melillo and Leisman 2009).
1 Although the term ‘vocal tic’ is used extensively, some tics, such as
sniffing, do not engage the vocal chords; thus, the term phonic tic is a
more accurate representation of the phenomenon.
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GTS has been genetically linked with OCD and ADHD
(suggesting that they are part of a spectrum), although
their profiles are notably dissimilar (Barkley 1993; Albin
and Mink 2006). The incidence of ‘‘pure’’ or ‘‘uncom-
plicated’’ GTS is uncommon, present in only about 10 %
of the observed GTS population (Robertson 2000; Faraone
et al. 2003; Mohammadi et al. 2004; Pittenger et al. 2011;
Eapen and Robertson 2015; Ganos and Martino 2015). In
contrast, both OCD and ADHD present with low comor-
bidity rates, but show a higher prevalence in the general
population. Despite the very high comorbidity of GTS
with OCD and ADHD, the reverse comorbidity of OCD
and ADHD with GTS is typically reported to be only
about 2–7 % (Zohar et al. 1992; Barkley 1993; Denys
et al. 2004).
Based on clinical characteristics and comorbidities, GTS
may be subtyped into three categories: (1) ‘‘pure’’ GTS,
comprised primarily of motor and phonic tics; (2) ‘‘full
blown’’ GTS, which included copro-, echo-, and paliphe-
nomena; and (3) GTS?, which includes OCD, ADHD, and
other severe psychopathologies such as self-injurious
behavior, depression, personality disorders, etc.…
(Robertson 2000; Grados and Mathews 2009; Ganos and
Martino 2015). Comorbidities may provide the underlying
structure for the broad range of phenotypic expression, and
as such, are a key variable to explicating the complexity of
the clinical profile. Largely, pure GTS does not typically
present with severe motor or executive dysfunction,
although these individuals are suggested to exhibit more
obsessive–compulsive and self-injurious behavior and are
more ‘‘delinquent’’ than GTS ? ADHD, likely as a result
of rage or anger (Robertson 2000; Rizzo et al. 2007;
Cavanna et al. 2008). GTS comorbid with ADHD presents
with appreciable cognitive and behavioral disability, and
GTS co-occurring with both ADHD and OCD presents as
more heritable with motor tics appearing at an earlier age
(Grados and Mathews 2008, 2009). More often than not, it
is the disability resulting from comorbid symptomatology
rather than GTS itself which prompts a patient to seek
medical attention (Robertson 2000).
The predominance of comorbidities together with vari-
ations in tic phenomenology suggests dysfunction of mul-
tiple neurotransmitter systems (Buse et al. 2013). Although
the neurobiological basis of GTS is unclear, the effec-
tiveness of dopamine antagonists in relieving tics has given
rise to multiple hypotheses for its role in GTS (Buse et al.
2013). Further imaging, physiological and pathological
studies have indicated a pivotal role for the re-entrant
circuits of the cortico-basal ganglia–thalamo–cortical net-
work, thus implicating gamma-amino-butyric acid
(GABA) and glutamate as well (Felling and Singer 2011;
Draper et al. 2014), and suggesting the underlying problem
may be one of action selection (Mink 2001; Albin and
Mink 2006). Despite significant strides in the field, neither
the underlying neuropathological mechanism(s), nor the
primary initiation site(s) of dysfunction are fully
elucidated.
GTS may be managed pharmacologically, behaviorally,
or surgically, all of which aim at ameliorating symptoms.
Preferred pharmaceutical therapies are comprised of
antipsychotics or, in milder cases, amphetamines
(McNaught and Mink 2011). And while comprehensive
behavioral intervention therapy has showngood success, few
trained professionals are available as of yet (Piacentini et al.
2010; Capriotti et al. 2014). Severely afflicted patients tend
to be refractory to both behavioral and pharmacological
therapies and thus may opt for surgical intervention (Porta
et al. 2009a; Hariz and Robertson 2010; Sassi et al. 2011).
Historically, medically-refractory patients were treated
by neurosurgical ablation in a variety of targets with
diverse results (Hassler and Dieckmann 1970; Temel and
Visser-Vandewalle 2004; Singer 2010). Despite delivering
symptomatic relief in many cases, outcomes include
complications of mild to severe permanent deficits as well.
In 1999, however, deep brain stimulation (DBS) was
introduced as a possible alternative treatment (Vandewalle
et al. 1999). Since then, over 120 patients worldwide have
been reported to have undergone the procedure with
varying degrees of success (Sassi et al. 2011; Schrock et al.
2014). While the use of DBS is a relatively new remedy
available for treatment-refractory GTS, successful out-
comes have been reported in many cases (Maling et al.
2012).
A key factor to attaining optimal results is target
selection, a topic still under debate due to the complex
clinical profile presented by GTS patients (Porta et al.
2009b; Schrock et al. 2014). The most common target has
been the thalamus, which arguably has also been reported
to deliver the most efficacious overall outcomes in
response to stimulation. In fewer cases, the globus pallidus
internus has been targeted. Stimulation of this nucleus has
been shown to be effective for tic reduction. In a small
number of procedures, the anterior limb of the internal
capsule and nucleus accumbens (ALIC/NA) have been
targeted in order to address the behavioral aspects or
comorbidities (in particular OCD) associated with GTS
and/or as ‘‘rescue’’ surgeries (Servello et al. 2009). Owing
to its generally successful outcomes and proposed rever-
sible nature, DBS has become not only a preferred surgical
technique, but also a promising option for the treatment of
refractory GTS (Porta et al. 2009b; Maling et al. 2012;
Schrock et al. 2014).
In addition to a direct therapeutic role, the advent of
DBS provides a unique and powerful platform for inves-
tigation. Recordings from DBS targets can provide sub-
stantial insights into the neuropathophysiological
Brain Topogr (2017) 30:3–29 5
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mechanisms of GTS (Maling et al. 2012; Priori et al. 2013;
Israelashvili et al. 2015). Acute single unit and local field
potential (LFP) recordings from the thalamus reveal
bursting behavior, consistent with reports from thalamic
nuclei in various other neurological disorders (Priori et al.
2013). Chronic recordings from intra-thalamic networks
demonstrate the effects of DBS on the dynamic changes in
the spectral characteristics of LFPs in correlation with
clinical benefit (Maling et al. 2012). For patients
responding to therapy, a decrease in tic expression has been
correlated to an increase in gamma oscillations (Maling
et al. 2012). Additionally, changes in the cross-frequency
coupling of theta-gamma band activity have been corre-
lated with active improvement in symptomatology (un-
published results). These data provide evidence for the
functional relevance of oscillations in the pathophysiology
of GTS and support the role of the thalamus as a pivotal
component in GTS dysfunction.
Tic Expression
The cardinal feature of GTS is tics. As part of the funda-
mental dysfunction of the syndrome, they are nearly
automatically described as chronic and involuntary; how-
ever, closer examination of when and how they occur
adduces a far more intricate definition. Examination of
their transient stability dynamics as well as the volition
driving the act of ticcing will provide not only a better
understanding, but a more definitive characterization of
them within the confines of the disorder.
Tics fluctuate on both a short and long time scale across
their dimensional features (intensity, frequency and
severity). On short time scales, both motor and phonic tics
(together and independently) exhibit short-term periodicity
and ‘‘burst-like’’ behavior, often described as ‘‘bouts’’
(Peterson and Leckman 1998). Over longer epochs, these
fluctuations are expressed as waxing and waning. Rather
than being random, tic intervals exhibit structure in their
dynamics, such as self-similarity; period doubling; and
inverse power law scaling of the frequency distribution
(with tic interval frequency plotted as a function of tic
duration) (Peterson and Leckman 1998). The ‘‘bouts of
bouts’’ experienced by GTS sufferers, therefore, are not the
haphazard events commonly thought, but instead demon-
strate the properties observed in non-linear dynamical
systems. Within this framework, predictions of system
behavior should be possible, where for example one could
determine the dimensional features of tics across time
scales. Clinically, this is nontrivial as the constant and
seemingly erratic changes in tic expression (frequency,
type, severity, complexity, number, location) can confound
therapeutic strategies (Robertson 2000).
Overwhelmingly, ticcing is depicted as an action which
is performed in response to the strong somatosensory
sensations which generally precede a tic (Leckman et al.
1993; Woods et al. 2005; Leckman et al. 2010). As such,
these premonitory urges are both clinically important and
scientifically relevant for understanding GTS. The bodily
sensations of such phenomena correspond with the
anatomical region of the impending tic and are described as
a ‘‘need’’, ‘‘itch’’, or ‘‘ache’’ (Woods et al. 2005; Marsh
et al. 2007; Doyon et al. 2009; Leckman et al. 2010).
Insofar as they are a disturbance heralding an impending
dysfunctional state, they can be considered analogous to
the aura experienced by epileptics prior to a seizure.
However, premonitory urges are corporeal sensations
rather than a perceptual disturbance; occur typically on fast
time scales and in circumscribed areas; and elicit bodily
responses to relieve them. Such impellent urges are rep-
resentatively described by one subject as a feeling that she
would ‘‘burst’’ unless she was able to ‘‘physically tic’’
(Leckman et al. 1993).
This brings into sharp focus the dynamics of tic
expression and elucidates the ongoing debate about whe-
ther tics should be classified as voluntary, involuntary, or
unvoluntary/nonvoluntary (Singer 2005; Ganos et al.
2015b). Although the symptomatology of GTS is conven-
tionally characterized as the involuntary expression of tics,
it is the premonitory urges—which occur in over 80 % of
patients—that are unequivocally involuntary (Leckman
et al. 1993; Fahn et al. 2011; Cohen et al. 2013). The
confounding factor is that the large majority of sufferers
([90 %) report that they partly or wholly respond to these
involuntary premonitory urges with voluntary tics (Leck-
man et al. 1993; Woods et al. 2005; Doyon et al. 2009). In
fact, subjects report voluntary ticcing regardless of tic
severity, although a higher incidence of premonitory urges
has been correlated with an increase in both tic severity and
tic complexity (Ganos et al. 2015b). Thus, the conundrum
becomes clear: is a voluntary response to an involuntary
sensation truly voluntary when the urge is irresistible?
Perhaps more light can be shed on the topic by
employing objective electrophysiological measures as
opposed to subjective reporting. The Bereitschaftspotential
(BP) is an electrophysiological recording representing
‘‘free will’’ and the initiation of voluntary movement
(Kornhuber and Deecke 1965; Libet 1985). It represents
the cortical contribution to motor planning and precedes
movement. Volition is immediately preceded by activation
of the supplementary motor area (SMA) and premotor
cortex *1.2 to 0.5 s prior to movement, followed by
activation in the primary motor cortex *0.5 s to imme-
diately pre-action (Shibasaki and Hallett 2006). EEG
recordings from GTS patients reveal a complete lack of the
first phase and often a lack of the second phase of the BP
6 Brain Topogr (2017) 30:3–29
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during spontaneous ticcing, but express the BP during
imitation tics in all cases (Obeso et al. 1981; Hallett 2001;
van der Salm et al. 2012). This might clarify entirely the
question of voluntariness, but there is a confounding factor:
in some cases, movement made in response to external
triggers does not express a BP (Papa et al. 1991). It may
therefore be possible that the absence of the BP is a result
of tic response to the premonitory sensory urge, which acts
as an internal trigger.
Ganos et al. show a correlation between increased
interoceptive awareness and the intensity of bodily sensa-
tions referred to as premonitory urges in GTS (Ganos et al.
2015b). One interpretation of this is that the perception of a
premonitory sensation would be oversensitivity to an
internal somatosensory signal. Given the theory that the
discernment of voluntary action depends on a perceptual
discrimination in relation to a given threshold level,
internal signals unrelated to volition could be misconstrued
as voluntary movements if the internal somatosensory
signal is above said threshold (Ganos et al. 2015a, b).
Premonitory phenomena have been associated with matu-
ration and an increased awareness of interoceptive sensa-
tion (Rajagopal and Cavanna 2013; Ganos et al. 2015b).
Younger children tend to not be aware of premonitory
sensations and also do not report ticcing voluntarily.
The insula is implicated in interoception and bodily
sensations and, together with the somatosensory and
medial frontal areas, has been consistently shown to be
overactive in tic generation in GTS patients (Tinaz et al.
2015). It has been suggested by Tinaz et al. in a study
demonstrating differences in the connectivity patterns of
the right dorsal anterior insula in GTS versus controls that
the insula could be involved in the increased awareness of
premonitory sensations, leading to the urge to tic (Tinaz
et al. 2015). Interestingly, although high interoceptive
awareness has been associated with greater premonitory
urges, subjects with GTS exhibit lower overall levels of
interoceptive awareness as compared with healthy controls
(Ganos et al. 2015b).
Given these subjective and objective reports, and the
clear struggle nonetheless to check such debilitating sen-
sory phenomena, the term unvoluntary seems the most
authentic when describing volition in ticcing. The aware-
ness and role of internal signals in the body and the
accurate characterization of tics—which are identified as
unwanted behaviors—have important implications for the
biological basis of the disorder and are clinically valuable,
in particular when targeting therapies.
There is a disparity in the incidence of premonitory
urges with respect to tic classification (Jankovic and Stone
1991; Leckman et al. 1993; Woods et al. 2005). Although
dystonic tics are most often associated with them, signifi-
cant differences have been found between the correlation
of simpler motor (dystonic) tics and premonitory urges
(Leckman et al. 1993; Jankovic 1997). For example, eye-
blinking and mouth movements have been reported to be
less frequently preceded by premonitory urges (*30 %) as
compared with shoulder jerks or head/neck movements
(*60 %) (Leckman et al. 1993). This pattern also appears
in phonic tics, albeit to a lesser extent, where sniffing has
been reported at an approximate 30 % frequency of co-
occurrence, while vocal tics were around 40 %. Correla-
tions have also been shown between tic frequency, inten-
sity, and complexity and premonitory urges in older youths
but not younger ones (Woods et al. 2005). Premonitory
sensations are overall reported by both genders nearly
equally (except notably in association with throat clearing
tics where female subjects reported nearly double the fre-
quency of males); occur mostly in the palm, shoulder, and
midline abdomen, and throat; and are typically (40 %) felt
in muscle, but can occasionally also be found in joints and
skin (Cohen and Leckman 1992)..
Tic expression can be influenced by contextual variables
from either internal or external environmental cues which
can affect both their frequency and severity (Marsh et al.
2007; Conelea and Woods 2008; Capriotti et al. 2014).
Classically, it has been reported that tic-exacerbating
variables include fatigue, social activities, or any envi-
ronment which increases stress or anxiety (Conelea and
Woods 2008). Tic-ameliorating factors include being in a
quiet comfortable environment, sleep, and focused atten-
tion on a task (such as music or athletic performance, or
math) (O’Connor et al. 2003; Conelea and Woods 2008).
These contextual antecedents are reported from case study
or descriptive design studies, which do not control for
threats to both internal and external validity and cannot
reliably address causal relationship.
In contrast, single-case experimental design investiga-
tions are inherently constructed to address causality. They
indicate the factors that most influence tic expression: overt
observation and the presence of others; reading and aca-
demic tasks; and tic related conversation and verbal
instructions to suppress tics (Conelea and Woods 2008). In
the latter case, verbal instructions resulted in reduced tic
frequency in nearly half of the subjects with no apparent
rebound effects (Meidinger et al. 2005). Interestingly,
vocal—but not motor—tics increased in the tic-related talk
condition (Woods et al. 2001). This is consistent with the
suggestion that in some cases, tic location may be func-
tionally related to the engaged activity (O’Connor et al.
2003). Similarly, tics were reported to occur more fre-
quently during less challenging reading tasks or conditions
(Watson et al. 2005), indicating focused attention is in fact
relevant for amelioration of tics. Finally, in a large cohort
of individuals with Chronic Tic Disorder, it was shown that
overt observation (with a camera) significantly increased
Brain Topogr (2017) 30:3–29 7
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tic frequency when compared to covert observation (hidden
camera) (Piacentini et al. 2006). Notably, the overt obser-
vation resulted in increased ticcing regardless of the
physical presence of another. Furthermore, tic expression
rates were independent of setting (home vs. clinic), and
remained remarkably temporally stable across locations.
The results of these studies provide empirically confirmed
findings which are non-trivial for symptom management
and evaluation in clinical practice.
Genetic Factors
Tourette syndrome likely arises from complex genetic
features that interact with environmental factors (Leckman
et al. 1997). Transmission has been shown to be autosomal
dominant, polygenic, and bilineal (Pauls and Leckman
1986; Hanna et al. 1999; Ali et al. 2013). One of the main
risk factors is male gender, as it is 3–5 times more
prevalent in boys as compared with girls (Kadesjo and
Gillberg 2000). The disorder is highly heritable: (1) the
incidence of GTS increases 10–100 fold if a primary rel-
ative has the disorder, (2) the incidence of GTS increases
5–20 fold if a primary relative has chronic tic disorder, and
(3) studies of monozygotic and dizygotic concordance have
reported between 50–94 % and 10–56 %, respectively, if
one sibling had GTS and/or tic disorder (Price et al. 1985;
Hyde et al. 1992).
Despite a strong hereditary component, Tourette syn-
drome presents with a range of clinical phenotypes and is
therefore often considered to be a genetically heteroge-
neous disorder (Jankovic 2001; Grados and Mathews 2009;
Ali et al. 2013; Cavanna and Rickards 2013). Presently, the
most prominent chromosome aberration is associated with
the SLITRK1 gene on chromosome 13 (Abelson et al.
2005). This gene has been shown to control neurite out-
growth and is expressed in the cortex, thalamus and basal
ganglia, all areas intimately implicated in the pathophysi-
ology of Tourette syndrome (Abelson et al. 2005; Proenca
et al. 2011). Another locus of interest is on chromosome
15, the L-histidine decarboxylase (HDC) gene (Ercan-
Sencicek et al. 2010; Karagiannidis et al. 2013; Castellan
Baldan et al. 2014). The enzyme expressed by this gene
converts L-histidine to histamine, which in turn regulates
neurotransmission. Clearly, any alteration in this gene
could lead to dysregulation of the information processing
necessary for proper motor, cognitive, and executive
function. Indeed, observations of HDC-deficient related
symptoms in humans were later supported by animal
experiments, in which similar sensorimotor and behavioral
symptomatology was reproduced in mice (Castellan-Bal-
dan et al. 2014). Although these are the most promising
leads in the search for the genetic underpinnings of the
disorder, both of these genetic anomalies are thus far
considered to be rare functional variants found in only a
small proportion of the disease population.
Looking for more common forms of genetic variation
which distinguish a substantial portion of the Tourette’s
population from the population at large, the first genome
wide association study (GWAS) for GTS was published in
2012 (Scharf et al. 2013). Although some aberrant genes
were found, this investigation could not report any com-
mon genetic variants that could be identified as risk factors
among about 1500 subjects with Tourette syndrome as
compared to over 5000 without it (Scharf et al. 2013).
These results suggest either a rare single gene or, more
plausibly, a multifactorial genetic effect might be con-
tributing to the etiopathology. A GWAS combining GTS
and OCD published 1 year later confirmed true functional
variants associated with gene expression levels in the brain
for each disorder (Yu et al. 2015). Interestingly, it proposed
that these highly comorbid disorders likely do not share a
genetic architecture, but rather have a complex genetic
relationship.
There may be inherent difficulties to isolating specific
risk genes which would unequivocally link to a seemingly
heterogeneous disorder such as GTS. The alternative
technique of gene network analysis, which reconstructs
functional gene networks from the susceptible genes in
disease-associated loci, may address this issue. A current
study using transcriptome analysis of post-mortem striatal
tissue has identified significant changes in the expression of
gene clusters in the brain tissue of lifelong sufferers with
severe GTS (Lennington et al. 2016). Ten modules of co-
expressed genes revealed 309 down-regulated interneuron-
related genes and 822 up-regulated immune-related genes.
No significant correlation was found between the expres-
sion of the two classes of transcripts, suggesting that they
may independently contribute to GTS pathophysiology.
Thus, decreases in the signaling of various classes of
interneurons in the striatum as well as aberrant activation
of the immune system could each be contributing factors to
dysfunction.
Anatomy and Pathophysiology
In addition to genetic studies, electrophysiological, imag-
ing and modeling investigations have provided many new
insights into the possible pathomechanism(s) of GTS; still,
its etiopathology has yet to be elucidated. Nonetheless, it is
believed that Tourette syndrome results from dysfunction
in the cortico-basal ganglia–thalamo–cortical network
(CBGTC) (Leckman et al. 1997; Mink 2001). The circuits
of the CBGTC are reported to control motor, emotional,
and adaptive function as well as the ability to reason
8 Brain Topogr (2017) 30:3–29
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(Schultz 2004; Leisman et al. 2014). Although its precise
mechanisms are still being actively investigated, impair-
ment has been suggested to be architectural, as observed in
altered connectivity patterns; physiological, as reported in
abnormalities of dopamine transmission; morphological, as
noted in the structural changes in the striatum and/or var-
ious regions of the cortex; metabolic, as revealed in cortical
PET scans; or functional, as demonstrated by changes in
the synchronization of neuronal ensemble activity (Wong
et al. 2008; Draganski et al. 2010; Maling et al. 2012; Cui
et al. 2014; Shprecher et al. 2014).
The CBGTC is purported to be essential for action
gating and the conversion of goal-directed behavior to
automated behaviors (Graybiel 2005; Doyon et al. 2009;
Haber and Calzavara 2009; Draganski et al. 2010). The
basal ganglia are involved in learning and memory and
essential to optimal control of action (Graybiel 2005). With
afferents from nearly all the functional subdivisions of the
cortex as well as connections to motor; prefrontal; parietal;
and temporal associative cortical areas via substantial
efferents from its output nuclei to the thalamus, this largest
subcortical structure in the human forebrain, which also
spans the midbrain and diencephalon, is well-positioned to
integrate motor, cognitive, and affective-motivational
processes (Graybiel 2000; Hammond et al. 2007).
Dysfunction in the basal ganglia is clinically expressed
in a range of movement and neuropsychiatric disorders,
and in addictive states (Graybiel 2005). Anatomic and/or
functional pathology in this network could understand-
ably give rise to the signs and symptoms observed in
GTS and GTS-related neurobehavioral disorders such as
OCD and ADHD. Functionally, abnormalities in the
associative and limbic circuits of the network have been
associated with OCD, while structurally, reduced volume
in the globus pallidus has been associated with ADHD
(Aylward et al. 1996; Worbe et al. 2012). GTS patients
exhibit both structural and functional alterations involving
multiple re-entrant pathways of the CBGTC (Leckman
et al. 2010).
The predominant models for dysfunction have been
based on either insufficient inhibitory motor control due to
decreased inhibitory output from the basal ganglia, which
would result in frontal cortical hyperactivation as a result
of thalamic disinhibition, or imbalance in the selection
and suppression of competing motor programs in which
desired behaviors are facilitated and unwanted ones are
inhibited (Mink 2001; Albin and Mink 2006). Cortical
dysfunction has also been proposed as a mechanism for
GTS pathophysiology (Thomalla et al. 2014; Tinaz et al.
2014). In particular, the anterior cingulate cortex (ACC),
insula and SMA have been implicated as they are believed
to be important for urge and impulse control (Hallett
2015).
Circuitry
The central cortical and subcortical regions in the patho-
genetic circuit include the (1) motor and associated motor,
prefrontal, and limbic cortices; (2) striatum [caudate,
putamen, and nucleus accumbens (NA)]; (3) globus pal-
lidus [internus (GPi) and externus (GPe)], (4) substantia
nigra [pars reticulata (SNr) and parts compacta (SNc)], (5)
subthalamic nucleus (STN), and (6) thalamus (see Fig. 1a).
The extrinsic connections of the pedunculopontine nuclei
and the cerebellum may also be important for the neu-
ropathological architecture of the disorder.
The cortex sends massive projections to the subcortex,
with the striatum and STN as the receiving stations for the
basal ganglia (see Fig. 1b). The striatum receives cortical
afferents that are both convergent (from multiple anatom-
ically separate but functionally related cortical areas) and
divergent (one cortical area projecting to multiple striatal
locations) (Flaherty and Graybiel 1991). It also receives
substantial afferents from the intralaminar and ventrolateral
thalamic nuclei and the SNc in addition to intrastriatal
inputs. The striatum is thus a regulatory center in which
information can be integrated, filtered and transformed.
The GPi/SNr, which are considered to be a single structure
divided by the internal capsule, are the basal ganglia output
station. They further integrate inputs from other basal
ganglia components and send their projections predomi-
nantly to the thalamus, but also to brainstem nuclei
(Nambu 2015). The GPe connects these input and output
stations, and the SNc modulates the network (Bar-Gad and
Bergman 2001; Rivlin-Etzion et al. 2006).
The CBGTC consists of multiple, parallel circuits
named for their cortical areas of origin and action (see
Fig. 2a) (Wichmann and DeLong 1996). The prototypical
structure is one in which somatotopically specific projec-
tions from a designated frontal cortical area synapse onto
their corresponding basal ganglia targets, which in turn
project topographically to the thalamus; the circuit is
completed by topographically maintained thalamocortical
projections. Thus, each functionally distinct cortical area
synapses onto its corresponding functional subdivision of
subcortex and this organization is faithfully preserved
throughout the circuit. The major circuits include the
motor, prefrontal/associative, limbic, oculomotor, and
orbitofrontal loops.
In general, motor circuits compose the dorsolateral
division and limbic circuits travel through the ventromedial
regions. As projections from the frontal cortex follow
topographic organization through the subcortex, each cir-
cuit is devoted to its discrete behavioral function. These
discrete circuits were initially thought to be structurally and
functionally segregated and thus ‘‘closed’’; however, some
intermixture between these pathways has been
Brain Topogr (2017) 30:3–29 9
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subsequently suggested, and is necessary for the perfor-
mance of such tasks as the learning and execution of
appropriate behavioral responses (Alexander et al. 1986;
Joel and Weiner 1994; Haber and Calzavara 2009). Inte-
gration within the network is the foundation upon which
motivation is translated into movement-requiring, goal-
oriented behavior and, ultimately, habit formation (Frank
2009; Maia and Frank 2011; Moustafa et al. 2014).
The CBGTC consists of mono- and poly-synaptic ‘‘di-
rect’’ and ‘‘indirect’’ pathways (see Fig. 2b) which are
organized topographically and distinguishable histologi-
cally (Kalanithi et al. 2005; Haber and Calzavara 2009).
Historically, the direct and indirect pathways were believed
to effect the mechanism of motor control by tandem
operation. In the direct pathway, excitatory input from the
cortex activates inhibitory output from the striatum which
suppresses the spontaneously active basal ganglia output
nuclei’s (GPi/SNr) inhibitory output, thus disinhibiting or
releasing the thalamus (see Table 1). This is the mecha-
nism suggested for motor program selection. By modulat-
ing inhibition at multiple levels, the indirect pathway
delivers a net excitatory effect on the GPi/SNr, causing
thalamic inhibition and the suppression of alternate,
unwanted motor behaviors.
This dualistic model eventually gave way to a new tri-
partite theory which includes the ‘‘hyperdirect’’ pathway.
In the hyperdirect pathway, information is monosynapti-
cally communicated from motor and non-motor cortical
areas to the STN, bypassing the striatum. Information can
then travel to the thalamus with faster conduction times via
direct efferents from the STN to the GPi/SNr. This
scheme creates a triphasic temporal effect on the thalamus
(Nambu et al. 2002). Via the fast conducting hyperdirect
pathway, the thalamus is initially inhibited; it is then sub-
sequently disinhibited by the direct pathway, with the
indirect pathway finally exerting inhibition once more. This
arrangement could allow for precise selection of action,
with a circumscribed initiation and termination.
In addition to this temporal organization, communica-
tion between nuclei of the CBGTC also exhibits a distinct
spatial organization due to differential anatomical con-
nections. An example of this is the powerful striatal and
STN efferents which are of opposite polarity, but converge
upon individual pallidal neurons (in both segments of the
globus pallidus). Although converging on a single cell, the
STN-pallidum fibers provide broad arborizations synapsing
onto the proximal dendrites of pallidal neurons with highly
branched collaterals closely surrounding their somata,
























bFig. 1 The cortico-basal ganglia–thalamo–cortical recurrent net-
work. a Subcortical structures of the CBGTC network. Three
dimensional visualization illustrates intimate topography of the
subcortical constituents of the CBGTC. Figure modified from
(Lenglet et al. 2012). b Schematic of the direct, indirect and
hyperdirect pathways of the cortico-basal ganglia–thalamo–cortical
network. A complex organization of highly interconnected structures
orchestrates the cognitive, motor, and emotional processes underlying
the repertoire of human behaviors. The striatum is the input nucleus
for the basal ganglia (beige circles), which receives excitatory
glutamatergic afferents from the cortex. It sends GABAergic
inhibitory projections broadly to the both divisions of the globus
pallidus and substantia nigra. The so-called ‘‘direct’’ and ‘‘indirect’’
pathways are based on the classification and connections of striatal
efferents. The direct pathway (highlighted in beige) projection is
monosynaptic to the GPi/SNr and expresses D1 dopamine receptors,
substance P, and dynorphin. The indirect pathway (dashed lines)
projects polysynaptically to the GPi/SNr and expresses D2 dopamine
receptors, enkephalin, and neurotensin. The indirect pathway has a
short and a long route. The short route affects the GPi/SNr via the
GPe, while the long route adds a further connection with the STN
before finally synapsing on the GPi/SNr. The hyperdirect pathway
(highlighted in purple) bypasses the striatum, allowing the cortex to
powerfully excite the GPi/SNr with fast conduction times. The
activity of the entire basal ganglia is modulated by the dopaminergic
cells of the SNc. GPi globus pallidus internus, SNr substantia nigra
pars reticulata, GPe globus pallidus externus, STN subthalamic
nucleus, SNc substantia nigra pars compacta. Copyright Rowshanak
Hashemiyoon (Color figure online)
10 Brain Topogr (2017) 30:3–29
123
embrace pallidal dendrites (see Fig. 3) (Hazrati and Parent
1992a, b). This contributes to a ‘‘center-surround’’ orga-
nization (see Fig. 4) (Nambu 2007).
The configuration of this dynamic spatio-temporal
model is purported to actualize the coordination of vol-
untary actions (Nambu et al. 2002; Haber 2008). Desired
actions are allowed by focused activation (via disinhibi-
tion) on a longer timescale of the circumscribed center area
of thalamic neurons via the direct pathway. In contrast and
in parallel, the hyperdirect and indirect pathways, involv-
ing subthalamo–pallidal connections, produce extensive
activation of the output nuclei of the basal ganglia,
Fig. 2 Anatamo-functional organization of the circuits of the CBGTC
network. a Re-entrant circuits of the CBGTC form functionally and
anatomically distributed, parallel circuits which integrate to perform
massive processing in different brain areas collectively serving the
same function. Disturbances are observed in motor, limbic, and
associative functions in Tourette syndrome. The motor loop is derived
from the primary motor, premotor, and supplementary motor cortex;
the associative loop is derived from the dorsolateral prefrontal cortex;
the limbic loop is derived from the anterior cingulate and orbitofrontal
cortex. Figure modified from (Volkmann et al. 2010). Anatomical
abbreviations as in Fig. 1b. b Anatomical representation of the human
motor CBGTC with the direct, indirect and hyperdirect pathways
illustrated using diffusion tensor imaging. All pathways originate from
the cortex and make variable successive (and some branched) synaptic
connections en route to the GPi/SNr. The thalamus receives organized,
synthesized information from the GPi/SNr. In turn, it performs further
processing and integration of impulses before conveying such to the
cortex. Arrows indicate excitation while vertical bars indicate
inhibition. Data collected from thirty subjects participating in the
human connectome project; rendering generated with TrackVis
software with subcortical structures based on the Harvard-Oxford
and Atlasing of the Basal Ganglia atlases. Modified fromAndreas Horn
(own work) [CC BY-SA 4.0 (http://creativecommons.org/licenses/by-
sa/4.0)
Brain Topogr (2017) 30:3–29 11
123
resulting in inhibition of large areas of thalamus and the
cancellation of unwarranted, competing motor programs.
The physiology and microanatomy of the circuit provide a
temporal and spatial organization which tightly controls
action gating. Activity imbalance in these pathways is
shown to produce a range of hypo- and hyper-kinetic dis-
orders, such as Parkinson’s and hemiballismus.
This imbalance between facilitation and inhibition has
also been implicated in habit formation. The conversion of
a desired motor program (goal-directed behavior) into a
habit (automated responses) requires proactive inhibitory
control and the participation of the associative and motor
circuits of the CBGTC, respectively (Aron 2011; Jahan-
shahi et al. 2015). The suppression of tics in response to
premonitory urges postulates the imposition of goal-di-
rected inhibition. Investigations of spontaneous versus
imitation tics suggest the former are due to either a
reduction in the activation of the mechanisms of habitual
inhibition or hyper-active generation of habitual actions
(Jahanshahi et al. 2015).
The modulatory role of dopamine (DA) in the CBGTC
is crucial for learning habits and for driving the transition
between goal-directed behavior and habit formation (Wong
et al. 2006). Reinforcement learning is suggested to occur
in part due to the dopaminergic cells of the SNc. These
neurons code reinforcement prediction errors which signal
the difference between observed versus predicted events
(Nambu 2008; Maia 2009). Such salient stimuli direct the
responsiveness of striatal projection neurons, in part due to
the ability also of the SNc to alter synaptic efficacy at the
cortico-striatal synapse (see Fig. 5) (Leckman et al. 2006;
Nambu 2008). This reinforcement of salient stimuli con-
tributes to habit formation.
Children and adults with GTS present with impaired
habit learning such that rate of learning inversely correlates
with tic severity (Marsh et al. 2004). Perturbation of DA
neurotransmission and decrease in intrastriatal inhibition
are factors that could give rise to each, respectively. Such
pathologies have been reported. The efficacy of DA
antagonists in relieving tics has led to a predominant theory
of DA dysfunction, and various studies report structural
changes in the striatum, including a decrease in the number
of parvalbumin-immunoreactive striatal interneurons
(Kalanithi et al. 2005; Kataoka et al. 2010; Buse et al.
2013).
There is much support for CBGTC in the pathophysi-
ology of Tourette, but other brain regions may also
engender GTS dysfunction. Numerous other areas have
been targeted as regions of interest in GTS, either via direct
interaction with the CBGTC or through different
Fig. 3 Characterization of basal ganglia synapses. The GPi receives
input from basal ganglia nuclei via the direct and indirect pathways. It
has been shown that both the strongly inhibitory cells of the striatum
and the powerfully excitatory cells of the STN send efferents
converging upon single pallidal cells (Hazrati and Parent 1992a). The
micro-architectural arrangement of these inputs is an important
determinant for the integration and transformation of information.
Direct input from striatal efferents closely embraces distal GPi
dendrites (yellow circles) while their polysynaptic input via the GPe
forms a tight pericellular arrangement on the somato-dendritic
domain (orange circles). The latter produce a strong inhibitory effect
because of their size and location on the post-synaptic pallidal
neurons. STN-pallidal (both GPi and GPe) fibers produce a strong
excitatory effect directly on the cell bodies (red circles), but also exert
some influence on pallidal dendrites with their collaterals that loosely
entwine them. The small terminals expressed by the STN on distal
GPi dendrites are much fewer than the striato-pallidal synapses by
comparison. Figure modified from Hazrati and Parent (1992a) (Color
figure online)
Table 1 Pathways and their neurotransmitter effects
Pathway Major synaptic neurotransmitters Effect on GPi/SNr GPi/SNr output Thalamic output
Direct Glutamate, GABA Inhibitory ; :
Short indirect Glutamate, GABA, GABA Disinhibitory : ;
Long indirect Glutamate, GABA, GABA, Glutamate Excitatory : ;
Hyperdirect Glutamate, Glutamate Excitatory : ;
Major neurotransmitters released in the pathways of the CBGTC at their synaptic target nuclei. All pathway effects are presented beginning with
the cortico-striatal synaptic connection and ending in the GPi/SNr. Activity in the GPi/SNr inversely affects thalamic activity
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mechanisms. Foremost among these is the cerebellum,
owing to its role in motor function as well as learning and
plasticity (Tobe et al. 2010). Unlike basal ganglia diseases
which are associated with impairment of involuntary
movement, cerebellar disorders are associated with failing
of voluntary movement. The role of the cerebellum in the
pathophysiology of GTS was most recently supported in an
investigation in which vocal and motor tics were induced
by focal disruption in ventral and motor striatum, respec-
tively (McCairn et al. 2016). Interestingly, metabolic
observations in those experiments also implicated the
hippocampus and amygdala, although the other subcortical
nuclei of the CBGTC were not associated. Additional
implicated nuclei include the pedunculopontine, with its
reciprocal connections to the STN, and dorsal raphe, due to
their projections to DA neurons.
Pathology: Anatomic
Prevailing theories suggest the disturbances observed in
GTS and its associated comorbidities arise as a conse-
quence of disturbances in the structural and functional
components of the CBGTC-namely the cortex, basal gan-
glia and thalamus. Alteration of brain morphological
parameters in adults includes changes in both gray and
white matter (Liu et al. 2013). Structural changes have
been reported in the prefrontal cortex, limbic structures and
basal ganglia of individuals with GTS, consistent with the
dysfunction and natural history characteristic of the disor-
der (Singer et al. 1993; Hyde et al. 1995; Peterson et al.
2003; Bloch et al. 2005; Plessen et al. 2009). Reduction in
caudate volume has been correlated with symptomatology
in both children and adults (Hyde et al. 1995; Peterson
et al. 2003; Bloch et al. 2005). Childhood caudate volume
was observed to be a predictor of symptom severity in early
adulthood (Bloch et al. 2005). In a longitudinal magnetic
resonance imaging (MRI) study, Bloch et al. showed a
strong inverse correlation between caudate volumes in
children and tic severity and OCD symptomatology later in
life. In contrast to this, an MRI study of monozygotic
twins, concordant for the presence of GTS but discordant
for its severity, while finding a slightly reduced right
caudate volume in the more severely affected twin,
nonetheless emphasized the proportional loss of ventricular
asymmetry to the degree of clinical severity (Hyde et al.
1995). MRI in a large cohort of GTS sufferers demon-
strated reduced bilateral cerebellar surface volumes pro-
portionally correlated with increased tic severity (Tobe
Fig. 4 Center-surround model for action selection. Schematic dia-
gram represents the contribution of the direct, indirect and hyperdirect
pathways to motor action selection. Cortical input travels serially
from the striatum to the GPi/SNr to the thalamus in the direct pathway
(center figure). Inhibitory GABAergic input from the striatum to the
spontaneously active pallido-nigral target results in disinhibition of
the thalamus, allowing it to activate the cortex and select the desired
motor program. Sequential effects of cortical input on the spiking
activity of these structures in the direct pathway are represented in the
right panel. Excitatory STN input from the hyperdirect and indirect
pathways—working on both a faster and slower time scale,
respectively—has broad spatial effects on the GPi/SNr. These
pathways are suggested to effectuate precision initiation and termi-
nation of selected motor programs in addition to inhibiting
unwanted/competing ones. Effects of cortical input on spiking
activity in the hyperdirect and indirect pathways are represented in
the hypothetical time series in the left panel. The hyperdirect pathway
is represented to the left of the indirect pathway in both panels to
indicate timing effects on the neuronal stream. The physiology and
microanatomy of the circuit provide a temporal and spatial organi-
zation which tightly controls action gating. Figure modified from
Nambu (2008)
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et al. 2010). For OCD comorbid cases, the results were
reversed with increasing hypertrophy in the lateral cere-
bellar hemispheres bilaterally, correlated with progres-
sively more severe OCD symptoms.
Various imaging studies have shown decreases in the
volumes of the caudate, putamen, and globus pallidus.
Neuropathological studies have also shown structural
alterations. The sensorimotor caudate and putamen showed
a 50–60 % decrease in the number of interneurons. In the
pallidum, the GPi has shown increases in the total number
of parvalbumin expressing neurons, while the GPe and
caudate showed a decrease in the number and density of
these cells (Kalanithi et al. 2005; Kataoka et al. 2010).
Careful examination of the literature reveals some
inconsistencies and conflicting results using imaging and
other indirect techniques. Such contradictions need to be
Fig. 5 Neuromodulation of striatal afferents and efferents. aMedium
spiny neuron. Image of medium spiny neuron (MSN) showing
dendritic spines, with spine neck and spine head clearly identified.
Neuron with Enhanced Green Fluorescent Protein imaged using laser
scanning two photon microscope. b Neuromodulation of excitatory
glutamatergic cortico-striatal input by dopaminergic nigro-striatal
input. Cortical neurons make excitatory glutamatergic synapses on the
heads of the dendritic spines of striatal MSNs. The dopaminergic SNc
neurons exert modulatory control over cortico-striatal connections by
synapsing on the necks of MSN spines, affecting the efficacy of
cortical inputs via the widespread distribution of dopaminergic
receptors on the cell membrane. Additionally, the striatum is the
primary target of dopaminergic signals; thus, it is well-positioned to
regulate cortico-striatal plasticity. c Schematic diagram showing
micro-anatomical arrangement and associated biochemical interac-
tions of cortical, SNc and striatal neurons. This organization is the
mechanism by which dopamine exerts modulatory control over the
activity of the direct and indirect pathways and thus regulates
behavior. Striatal MSNs of the direct pathway are differentially
excited by D1 receptors which activate adenylyl cyclase, while MSNs
of the indirect pathway express predominantly D2 receptors which
inhibit adenylyl cyclase. Tic expression may be the result of excessive
activation of the direct versus indirect pathway, explaining the
success of D2 antagonists in relieving tics. The interactions of these
neurons at the level of the synapse can result in plasticity, such as
occurs as a result of activation of AMPA/NMDA and DA receptors.
D1R D1 subtype of the dopamine receptor, D2R D2 subtype of the
dopamine receptor, NMDAR N-methyl-D-aspartate receptor, AMPAR
a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor, AC
adenylyl cyclase, ATP adenosine triphosphate, cAMP 30,50-cyclic
AMP
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examined for matching parameters or confounding ele-
ments. For example, conflicting reports of volume increase
in the dorsolateral putamen could be attributed to other
qualifying factors, such as comorbid effects (from ADHD,
for example) or medication (Peterson et al. 2003; Dra-
ganski et al. 2010).
GTS subjects taking neuroleptics had significantly dif-
fering basal ganglia volumes when compared to healthy
subjects or to those not on medication (Peterson et al.
2003). Subjects taking typical neuroleptics tended to have
significantly larger caudate and globus pallidus volumes,
with the putamen and ventral striatum showing the same
trend (Peterson et al. 2003; Draganski et al. 2010). In
contrast, subjects taking atypical neuroleptics, had slightly
smaller caudate and putamen volumes, but larger globus
pallidus volumes. This volume-modifying effect was not
seen with a-adrenergic agonists, tricyclic drugs, or specific
serotonin reuptake inhibitors.
These results should be appraised in the context of the
known effect of neuroleptics on the basal ganglia. Inde-
pendent of GTS, they are recognized modifiers of basal
ganglia structure. For example, first generation (classic)
antipsychotics cause increases in caudate volume, while
second generation antipsychotics have the opposite effect.
In fact, switching from the former to the latter can reverse
the effects of the first generation antipsychotics, bringing
volumes back to normal. Such drug-related effects on
anatomical volumes should be considered when reporting
and interpreting results, both to temper over-interpretation
and to examine for drug-modified interactions with existing
changes in brain volumes.
As a broad range of motor and limbic cortical regions
are implicated in the dysfunctional network associated with
GTS, examination of their morphological changes could
provide insight into their role in the pathogenesis of GTS
(Peterson et al. 2001; Sowell et al. 2008; Thomalla et al.
2009). Increased volume has been shown in dorsal lateral
prefrontal and parieto-occipital regions with decreases in
inferior occipital volumes (Peterson et al. 2001). Addi-
tionally, decreased grey matter volumes were also observed
in the medial orbitofrontal, anterior cingulate and ventro-
lateral prefrontal cortices and operculum bilaterally (Dra-
ganski et al. 2010). Corpus callosum size was found to be
inversely correlated with dorsal lateral prefrontal and
orbitofrontal cortical volumes to a greater magnitude than
found in controls, and positively correlated with tic severity
(Plessen et al. 2004). In these studies, the size of the corpus
callosum was shown to be smaller overall in children and
larger in adults, correlating with the natural history of the
disorder. Reduced callosal size would limit interhemi-
spheric communication and result in diminished input to
inhibitory neurons in the prefrontal cortices.
Draganski et al. reported a negative correlation between
prefrontal cortical thickness reduction and tic severity
(Draganski et al. 2010). In adults, primary somatosensory
cortex and right dorsal premotor cortex showed increased
cortical thickness. Increased cortical thickness and grey
matter volume in the left primary somatosensory cortex
and prefrontal cortex were also positively correlated with
the intensity of premonitory urges. Morphological analysis
of the sensorimotor cortices controlling movement and
vocalization in affected children showed cortical thinning
in the frontal and parietal lobes positively correlated with
tic severity (Sowell et al. 2008).
Comorbidities and tic severity modulated grey matter
volumes (Draganski et al. 2010). In particular, ADHD
comorbidity conferred significant effects. ADHD comorbid
subjects were observed to have substantial decreases in the
left inferior parietal cortex and posterior hippocampus
bilaterally, while OCD comorbidity was not correlated with
any changes. ADHD comorbidity also determined the
polarity of correlation between orbitofrontal cortex/ven-
trolateral prefrontal cortex thickness and tic severity, as
assessed by the Yale Global Tic Severity Scale (YGTSS).
Those with ADHD ? GTS or ADHD ? OCD ? GTS
were reported to show a negative correlation between
orbitofrontal cortex/ventrolateral prefrontal cortex thick-
ness and tic severity, while those with only OCD ? GTS
showed a positive correlation between thickness and tic
severity (Draganski et al. 2010). Nucleus accumbens vol-
ume was negatively correlated with severity of OCD.
White matter analysis has shown widespread abnor-
malities in both children and adults with GTS. Tic severity
has been reported to be inversely proportional with white
matter volume in the right frontal pole and positively
correlated with increases in axial diffusivity in children
(Liu et al. 2013). These subjects also showed a positive
correlation with mean diffusivity and tic duration. In
adults, intensity of premonitory sensations was negatively
correlated with fractional anisotropy (FA) values in the
parietal portion of the superior longitudinal fascicle (Dra-
ganski et al. 2010; Liu et al. 2013). Adults also showed
significant FA decrease in the genu of the corpus callosum,
and FA increase with mean diffusivity decrease was
observed bilaterally in the somatosensory area (Draganski
et al. 2010). Significant axial diffusivity and mean diffu-
sivity increases were reported in children in the anterior
thalamic radiation, right cingulum bundle projecting to the
cingulate gyrus, and forceps minor (Liu et al. 2013).
In a study using probabilistic tractography, as well as
FA and radial diffusivity to examine the hypothesis that
aberrant brain development affects the structural connec-
tivity of the CBGTC in adults with GTS, Worbe/Mar-
rakchi-Kacem et al. reported abnormally enhanced
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structural connectivity between the striatum and thalamus
with primary motor and sensory cortices (Worbe et al.
2015). The striatum and thalamus also exhibited abnormal
connectivity with the paracentral lobule, SMA and parietal
cortices. In the subcortical aspect of the CBGTC, enhanced
motor connectivity in the thalamo-putaminal tract showed
strong, positive correlation with tic severity. Microstruc-
tural abnormalities of white matter were found in the
pathways between the cerebral cortex, basal ganglia, and
thalamus. Interestingly, the microstructural axonal abnor-
malities of the cortico-striatal pathways showed gender
dimorphism as they were more prominent in females.
Pathology: Metabolic
Metabolically, fMRI studies have reported increased
activity in the paralimbic areas, SMA and parietal oper-
culum prior to ticcing (Bohlhalter et al. 2006; Hampson
et al. 2009). Of these, only the SMA was activated and
showed a broad cross-correlation with the motor cortex in a
natural versus imitation ticcing paradigm, suggesting a
neurophysiological correlate for the premonitory sensations
that precede and drive tic behavior (Hampson et al. 2009).
This theory is supported by electrical stimulation of the
SMA with subdural electrodes in human epileptic subjects,
which generated both movement and the urge to move
(Fried et al. 1991).
Bilateral SMA and lateral premotor cortex, as well as
midline activity, were shown to increase in 18F-fluo-
rodeoxyglucose PET measures, which also showed
decreased metabolic activity in the limbic caudate and
thalamus (Swain et al. 2007). In a similar study, no changes
in glucose metabolism overall within and between the
cerebral cortices were observed; however, the frontal and
temporal lobes bilaterally showed a relative hyperme-
tabolism in GTS patients (Chase et al. 1984). In particular,
an inverse correlation was shown between cortical meta-
bolism and severity of vocal tics in the middle and inferior
portions of the frontal lobes bilaterally, while coprolalia
was associated with the left parasylvian region. Addition-
ally, the basal ganglia—predominantly the striatum—ex-
hibited a 16 % greater glucose metabolism in GTS patients
than controls.
An event-related [15O] H2O PET synchronized with
audio- and video-taping exploring the duration and fre-
quency of tics showed abnormal brain activation in a dis-
tributed neural system including regions in the neocortical,
paralimbic and subcortical areas (Stern et al. 2000). Areas
associated with sensorimotor, language, executive, and
limbic functions such as the primary motor, supplementary
motor, premotor, anterior cingulate, and dorsolateral-ros-
tral prefrontal cortices; Broca’s area; insula; claustrum;
putamen and caudate were highly temporally correlated
with motor and phonic tics. These results support the the-
ory that GTS pathophysiology consists of a large scale
network that either spontaneously initiates motor and vocal
behavioral repertoires, or fails to suppress them.
An investigation which also employed [15O] H2O PET
in which vocal and motor tics were induced in non-human
primates reported a much smaller network with different
activated brain regions (McCairn et al. 2016). Injection of
the GABA antagonist bicuculline into the NA or dorso-
lateral sensorimotor putamen produced repetitive complex
vocalizations or motor tics in the orofacial and/or the arm
region, respectively. In the limbic circuit, unilateral disin-
hibition of the NA significantly increased regional cerebral
blood flow bilaterally in the anterior cingulate gyrus, the
amygdala and hippocampus. In the motor circuit, this
increase in blood flow was observed ipsilaterally (to
injection) in M1 and contralaterally in the cerebellum post-
putamenal injection. Motor tics were not concomitant with
vocal tics and each circuit maintained its unique regions of
bFig. 6 Increased gamma power correlates with symptomatology.
Comparative power spectra before and after chronic DBS therapy for
GTS are shown. Bipolar local field potential recordings are taken
from the DBS macroelectrode, chronically implanted in the CM
thalami of five patients. In order to faithfully represent the thalamic
network, the largest sampling of the neuronal population is taken
(channel 4 in all subjects; TS2 has a bilateral stimulator). A
correlation was found between increased synchronization of neuronal
ensemble activity in the gamma band and improved symptomatology.
Figure modified from (Maling et al. 2012). a DBS macroelectrodes.
Channel configurations for electrode recordings are shown. Channel
four has the largest sampling area, representing a larger network of
neuronal activity. b Electrophysiological recordings from five patients
1 month post-operatively (stimulator not yet turned on) (left graph)
and after 5 months (right graph). Motor and vocal tics were assessed
using the YGTSS. Patients who responded with significant symp-
tomatological improvements, reflected in lower YGTSS scores,
(responders), also showed significant increases in the spectral power
of local field potentials in the gamma range, indicating that GTS is a
disorder of hyposynchronization and that gamma oscillations may be
important to the pathophysiology of GTS. After several months,
patients one and five did not show significant clinical benefit (or
change in YGTSS) and displayed aberrant gamma synchronization (as
evidenced by the continued absence of gamma peaks over time).
Variation was found in the final lead (electrode) location as compared
with the others. The absence of a normal oscillatory regime combined
with electrode location disparities suggests that the stimulation of the
CBGTC network at the level of the CM thalamus addresses the
pathophysiological basis of GTS and ‘‘corrects’’ the resulting
dysfunction in signal transmission. c Acute stimulation correlates
with increase in gamma synchronization. Immediate increase in
thalamic gamma power was observed in response to acute DBS
stimulation in long term responders, indicating a physiological
importance for the role of gamma oscillations. Because changes in
synchrony are immediately observed in those who also derive the
greatest benefits from therapy chronically, gamma oscillations may be
critical to the pathophysiology underlying GTS and might be used as
a biomarker. Stimulus–response changes in gamma may be useful
intra-operatively in determining optimal target localization
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increased activation for corresponding tic type. These
results suggest: 1) vocal and motor tics are a resultant
property of the interruption of GABAergic communication
in specific striatal regions which produce circumscribed
circuit-wide increases in activation and 2) focal interrup-
tion in the limbic/motor circuit does not necessarily lead to
widespread shared dysfunction between the circuits in the
larger CBGTC.
Pathology: Functional
Significant alterations in the temporal patterning of neu-
ronal activity in the pathological circuit reflect changes in
information processing and may provide insight into the
underlying neurophysiological mechanisms of dysfunction
in GTS. The use of fractional amplitude of low frequency
BOLD fluctuations in resting-state fMRI allows a quanti-
tative measure with more focus on neuronal fluctuations
and can be applied in the study of neurophysiology of
neuropsychiatric disorders (Zou et al. 2008; Lai and Wu
2015). In such an investigation of drug-naı¨ve, pure GTS
(no comorbidity) children, significant decrease in func-
tional activity was measured in the amplitude of low fre-
quency fluctuations (ALFF) (0.01–0.1 Hz) and the
fractional ALFF (fALFF) in multiple relevant cortical
regions (Cui et al. 2014). Significant increase in the fALFF
was observed subcortically, including in the left putamen
and bilateral thalami. These results are consistent with the
prevailing model of GTS dysfunction of excess striatal
activity leading to increased thalamic activity and an
overexcited neocortex. Further support for this was found
in the observation that tic severity was positively correlated
with increased fALFF in the thalamus, ‘‘confirming its
putative role in the pathogenesis of TS.’’
In humans, the centre me´dian/parafascicular nucleus of
the thalamus (CM/Pf) is the primary source of thalamo-
striatal projections, sending massive efferents to the dorsal
striatum. The primate CM/Pf, via innervation of the
nucleus accumbens; caudate; putamen; and cortex, is part
of an extensive functionally-organized network with the
capacity to affect a broad range of basal ganglia functions
(Smith et al. 2014).
The physiological contribution of the human thalamus to
the network pathophysiology of GTS was elucidated in a
longitudinal study which recorded changes in thalamic
physiology over the course of DBS therapy (Maling et al.
2012). Local field potential (LFP) recordings from the CM/
Pf revealed a correlation between tic symptomatology and
spectral activity in the gamma band (see Fig. 6b). In
patients responding to therapy, a clear correlation was
shown between a decrease in tic severity and an increase in
the power of synchronized gamma oscillations. This study
demonstrated that, unlike other movement disorders in
which the CBGTC is implicated, GTS dysfunction is a
result of hyposynchronization in the thalamic network. The
results of this investigation help elucidate the role of
oscillations in GTS and offer insights into the basis of tic
genesis and expression.
Alteration of the functional connectivity between
regions within the CBGTC has also been described in
individuals with GTS (Jeffries et al. 2002; Tinaz et al.
2014). Observations from 18F-fluorodeoxyglucose PET
showed ventral striatum connectivity to be most prominent,
although changes in the premotor areas, SMA, and insula
were also been reported. Functional connections between
the motor and lateral orbitofrontal circuits were the same in
GTS patients and healthy controls, but the Tourette’s group
showed a reverse polarity such that their activity was
positively coupled (increased activity in one is correlated
with increased activity in the other). These data are col-
lected by indirect observations of metabolic coupling
between brain regions. Electrophysiological measures of
the directional neuronal connectivity in the network in
humans have not been reported to date and would con-
tribute to our understanding of the underlying functional
mechanisms of the pathophysiology of GTS (Hashemiyoon
et al. 2016).
Treatment Options
There is presently no cure for Tourette syndrome. Fur-
thermore, because almost all cases of GTS are co-occurring
with neurobehavioral disorders, therapeutic options must
aim at relieving tic severity and frequency in addition to
treating the often more troublesome comorbid symptoms.
As such, three features of GTS should be taken into con-
sideration when planning ameliorative strategies: (1) indi-
vidualized patient portrait, due to the variability of
symptom profiles that arise from a range of comorbidities;
(2) the waxing and waning of the location, frequency, and
intensity of symptoms, which can occur over a range from
minutes to months; and (3) the natural history of symp-
tomatology, which increases then decreases from early
childhood to adulthood. Treatment options are behavioral,
chemical and/or surgical as symptom severity increases or
as needed.
Due to new data on the efficacy of behavior therapy
(especially ‘‘habit reversal training’’), it is now recom-
mended as a first-line intervention treatment for GTS
(Verdellen et al. 2011; van de Griendt et al. 2013). While
these therapies are becoming increasingly more favorably
recognized as treatment options (in particular as safe and
effective for children), results are comparatively slow onset
and require further investigation to establish persistence of
ameliorative effects. As side effects are not an issue with
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this option, it could be recommended as a supplemental
add-on treatment, to be offered alongside other therapies.
Pharmacological interventions are typically introduced
in moderate to severe cases. In such indications classic
neuroleptics, which work as DA-antagonists, are still the
most commonly prescribed because of their ability to
relieve tic burden (Eddy et al. 2011). These drugs include
pimozide and haloperidol, which are FDA-approved
antipsychotics, or risperidone, which is first-option in
Europe (Roessner et al. 2011). For milder cases—if treat-
ment is recommended—a2-adrenergic agonists are indi-
cated, in particular where ADHD comorbidity occurs
(Robertson and Orth 2006; Singer 2010; McNaught and
Mink 2011). For isolated motor tics, botulinum neurotoxin
injections have been shown to be effective and well-tol-
erated (Kwak et al. 2000; Marras et al. 2001).
No tailored drug therapy has been developed for GTS;
therefore, pharmacotherapy consists of remedies borrowed
from other disorders, such as schizophrenia (McNaught
and Mink 2011). The use of antipsychotics, while effective
in alleviating motor symptoms, also gives rise to consid-
erable side effects (McNaught and Mink 2011; Ganos and
Martino 2015). This is due to their interaction with a range
of neurotransmitter systems, including the histaminergic,
serotonergic, cholinergic and alpha-adrenergic. This is a
major complication of the available pharmacotherapy and
thus compromises its practical effectiveness. The devel-
opment of neuroleptics with high efficacy and low side
effects, such as the now molecule-of-choice, Aripiprazole,
would greatly improve the options for pharmaceutical
intervention in GTS (Hartmann and Worbe 2013).
In medically refractory cases, where pharmacological
intervention cannot provide relief, surgery is an option.
Historically, surgical lesioning in a variety of target sites
has been performed in debilitating cases. These included
ablations in the thalamus, globus pallidus, frontal lobe
(bimedial frontal leucotomy and prefrontal lobotomy),
limbic system (anterior cingulotomy and limbic leuco-
tomy), and cerebellum (Hassler and Dieckmann 1970;
Temel and Visser-Vandewalle 2004; Singer 2010).
DBS and Electrophysiology
History
More recently, a safer surgical option, DBS, has been
introduced (Vandewalle et al. 1999; Sassi et al. 2011). The
procedure, which remains largely unchanged since its
inception, requires the electrical stimulation of deep brain
structures by chronically implanted electrodes which
receive high-frequency pulses from an often subcuta-
neously implanted pulse generator.
DBS is FDA-approved and carries the CE-mark for
movement disorders such as Parkinson’s disease and
essential tremor and has been recently approved in a neu-
ropsychiatric indication, OCD. Although it is not yet
approved in the treatment of GTS, the procedure has been
performed in over 120 patients in 25 centers across 14
countries since the first surgery in 1999 (Vandewalle et al.
1999; Mu¨ller-Vahl 2013; Schrock et al. 2014). The vast
majority of the 48 studies published since then target only a
single brain structure, with two targets in 10 cases and
three targets in one case (Schrock et al. 2014). The first
DBS surgery for GTS was performed in a 42 year-old male
whose tics decreased from 38 per minute to zero at
12 months post-operatively (Vandewalle et al. 1999).
Targeting: Surgical
The target described by Vandewalle et al. in this inaugural
case was in the medial part of the thalamus (Vandewalle
et al. 1999). The selection of this surgical focus was
motivated by the thalamotomies described by Hassler in
1970 (Hassler and Dieckmann 1970; Temel and Visser-
Vandewalle 2004; Singer 2010). The rationale for selection
was to obtain the same clinical effect on GTS symptoms
with the bilateral high frequency stimulation of DBS.
Hassler performed between ten and fourteen coagulations
in each hemisphere, in the medial, intralaminar and ven-
trolateral thalamic nuclei. In order to be able to stimulate
the three groups of nuclei targeted by Hassler, the strategic
point chosen was located at the intersection between the
anteromedial border of the centre me´dian nucleus of the
thalamus (CM), as part of the intralaminar thalamic nuclei;
the periventricular substance (substania periventricularis
(Spv)), as part of the medial thalamic nuclei; and the
nucleus ventralis oralis internus (Voi), as part of the ven-
trolateral thalamic nuclei. The trajectory for the electrode is
ideally along the longest axis of the Voi. Based on the
Schaltenbrand-Wahren atlas, the coordinates for this target,
in relation to the line connecting the anterior with the
posterior commissure (AC–PC line), are: 5 mm lateral to
the AC–PC line, 4 mm posterior to mid AC–PC line, and at
the level of the AC–PC line (depth coordinate).
This target has been adopted by some centers, and
slightly modified by others. For example, based on their
positive clinical results, Servello et al. utilize a target
which is 2 mm more anterior, while others stimulate the
center of the CM (Welter et al. 2008; Maling et al. 2012;
Servello et al. 2016).
Including the thalamus, target selection for DBS in GTS
has totaled nine distinct brain regions, aligned with the
functional neurobiopathology in the CBGTC circuit (Hariz
and Robertson 2010; Sassi et al. 2011). Although the
therapeutic potential of these targets is an area of active
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investigation, three brain regions are commonly implanted:
(1) the medial thalamic region with 70 reported cases, (2)
the GPi, with 30 cases reported (14 anteromedial (topo-
graphically limbic area), 16 posteroventral) and (3) the
ALIC/NA with 6 reported cases (Schrock et al. 2014).
Additionally, the GPe and the STN have each been
reported once as a target, the latter in a Parkinson’s patient
with tics. The most efficacious target appears to be the
thalamus, but it is also the region most often targeted for
surgical intervention.
Targeting: Functional
In addition to the reasoning mentioned above, Vandewalle
et al. based their choice of target on the hypothesis that the
application of DBS to it would lead to the modulation of:
(1) motor symptoms via stimulation of the CM, which
projects to the motor striatum (motor feedback circuit); (2)
behavioral symptoms via stimulation of the Spv, which
projects to the ventral striatum (limbic circuit); and (3)
facial tics (a predominant GTS symptom) via stimulation
of the Voi, because of its direct projections to the facial
part of the (pre-) motor cortex.
In the neurobiological dysfunction of GTS, the thalamus
is a key component both anatomically and functionally
(Haber and Calzavara 2009). It is intimately involved in
both the processes (such as emotions, motivation and
cognition) that lead to movement and the goal-directed
behaviors that require movement. It is well connected to
both the cortex and striatum. Located in the caudal part of
the intralaminar thalamus, the CM/Pf diffusely innervates
the motor, premotor and the prefrontal cortices (Parent and
Parent 2005). Furthermore, in addition to being the target
of integrated basal ganglia output, it projects dense clusters
of axon terminals to focally innervate the striatum (Mat-
sumoto et al. 2001). Beyond these, a third set of projection
neurons jointly innervates both the cortex and the striatum
(Parent and Parent 2005). These tightly connected func-
tional circuits signify the importance of the CM/Pf, which
has a pivotal role in the state setting modulatory system of
the brain (where it affects both arousal and attention) and is
intimately associated with the basal ganglia action-gating
circuit (Matsumoto et al. 2001; Parent and Parent 2005).
The CM/Pf is well-situated to synthesize, organize and
control the information transmitted to both the cortex and
striatum. In other words, the parallel and ‘segregated’
pathways of the CBGTC create a rich network with the
thalamus potentially ‘‘in the driver’s seat’’, modulating
other structures. The regulatory functions of the thalamus
are already well-documented in other systems (e.g. visual
and auditory). With the thalamus strategically positioned in
this widely distributed, finely tuned, complex network, its
use as a target for therapeutic DBS for GTS could resolve a
more inclusive range of symptoms related to motor func-
tion as well as emotion and cognition.
Targeted stimulation in alternative deep brain areas
should nonetheless be considered for highly circumscribed
disease dimensions. Due to its various and high number of
comorbidities, GTS presents with a broad phenotypic
range. For patients with a stronger functional bias, other
targets may be more therapeutically sensible for the relief
of specific symptoms. For example, the posteroventrolat-
eral part of the GPi could be selected for patients seeking to
relieve robust motor symptoms, while the ALIC/NA would
address neurobehavioral concerns such as obsessions and
compulsions.
Intra- and Peri-Operative Recordings
Despite a considerable body of work from imaging,
pathological and other studies to suggest mechanisms for
the pathophysiology of GTS, important questions still
remain. DBS has offered the opportunity for acquiring
direct evidence of the activity in one or more component
regions of the suspected pathophysiological pathway from
in vivo electrophysiological recordings in human patients.
Intra-operative recordings from drivable microelectrodes
present an opportunity for single unit recordings, while
post-operative recordings of local field potentials can be
made from implanted macroelectrodes. In 2010, the first
thalamic physiological data from seven GTS patients
undergoing DBS were reported from seven patients (Mar-
ceglia et al. 2010). Action potentials from single neurons in
the trajectory targeting the Vo complex revealed irregular
firing and oscillatory bursting at 4–6 mm and 1–3 mm
above target respectively. At target, a quiet zone was
reported although the authors suggest this may be due to
the activity of the zona incerta which is actually below
target.
Intra-operative single neuron recordings characterized
bursting in the posterior Vo region of the thalamus in
anaesthetized patients, consistent with low frequency tha-
lamic bursting reported in the thalamic nuclei of various
other neurological disorders (Marceglia et al. 2010; Priori
et al. 2013). Analysis of local field potential (LFP)
recordings in the same region in the same patients—while
not ticcing—2 days post-operatively exhibited prominent
oscillations in the delta, theta, and alpha range (Marceglia
et al. 2010).
In eight patients undergoing pallidotomy, similar
bursting activity, in addition to pauses in tonic activity, was
observed in the GPi in 45 % of recorded neurons (Zhuang
et al. 2009). Most of this activity was predominantly syn-
chronous (*71 %). A little over 25 % of these occurred
prior to EMG onset, mostly with increased activity
(*78 %), although some exhibited decreased activity
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(22 %). A very small percentage of recorded neurons
(*3 %) followed EMG onset. Pallidal neurons also
showed decreased neuronal firing rate and irregular pattern.
Acute and Chronic Recordings
Recordings from intra- and peri-operative studies offer a
precious opportunity to extract information directly from
the human brain in vivo. By themselves, however, they
face severe limitations. While the thalamic study reported
for the first time the electrophysiology of the Vo, the
neurophysiological properties described were neither
unique to the target nor to the disorder, GTS (Marceglia
et al. 2010; Priori et al. 2013). Additionally, no other
measures were taken to assure correlation to tic expression,
and LFPs were taken in the absence of ticcing. The
recordings of GPi neurons from patients undergoing pal-
lidotomy addressed this issue by utilizing EMG to show
correlation between neurophysiological behavior and tic
behavior.
These studies provide first approaches to gaining a better
understanding of the neurophysiology of relevant deep
brain nuclei in the human GTS brain; however, such acute
studies suffer from two major failings. First, they are
potentially confounded by the notable microlesion effect,
which can induce biochemical responses in neurons and
persist up to 2–3 months post-operatively (Granziera et al.
2008; Pourfar et al. 2009; Tykocki et al. 2013). Second,
they do not explain the underlying neurophysiological
dynamics that support the pathology and how these are
altered as a result of therapy. Such information must come
from chronic recordings from in-dwelling electrodes.
Recordings from electrodes implanted inside the human
brain offer a rare opportunity to observe neuronal behavior
correlated with disease state. In 2012, Maling/Hashemiy-
oon et al. reported on the first and only study to date from
direct, chronic recordings in the human CM thalamus over
the course of DBS therapy (Maling et al. 2012). This
investigation in a cohort of five subjects tracked over
6 months focused on the pathophysiological dynamics of
the thalamic network in response to a therapeutic modality.
Using the NeuropaceTM system, LFP recordings were made
from the implanted macroelectrodes of the DBS device and
analyzed in relation to GTS symptomatology. Temporal
analysis of the spectral characteristics of LFP recordings in
the CM thalamus was correlated with the clinical benefit
derived by each subject, typically tracked on a monthly
basis. The results of this study showed the first clinical
correlation between GTS symptomatology and a band-
specific oscillatory frequency. A clear correlation was
shown between a decrease in tic severity and an increase in
the power of gamma synchronized oscillations. Patients
with the best clinical outcomes over the duration of the
study also exhibited the largest increases in gamma power
at 6 months2 (see Fig. 6b). Non-responders to DBS did not
show significant improvement clinically and did not exhibit
gamma oscillations. Gamma band activity is characteristic
of normal thalamic information processing (Llinas and
Ribary 1993; Steriade et al. 1993, 1996). The therapeutic
effect of DBS may be the functional restoration of effective
communication. This is reflected in the increased syn-
chronization of neurons contributing to gamma synchro-
nized activity.
The short term effect of DBS on the thalamic network
was also tested. One minute DBS-OFF recordings were
taken during a relaxed awake state before and after 30 s
stimulation at the therapeutic settings. Spectral difference
plots showed a statistically significant increase in gamma
power in the right hemisphere of three patients, two of
them also responders in the chronic DBS data set (see
Fig. 6c). No significant changes were seen in any of the
patients’ left hemispheres.
As the first ever longitudinal study of the effects of DBS
on the dynamic changes in specific frequency bands in
human GTS patients, this study addresses a vital gap in our
knowledge of the neural correlates of symptomatology as
well as dynamic physiological responses to DBS therapy
over time. The results of this study suggest that dynamic
changes in gamma band power are relevant to the patho-
physiology underlying GTS, and support the hypothesis
that the CM thalamus is an important therapeutic focus in
its pathological circuit dysfunction.
Network Dynamics
The functional relevance of the thalamic network is sug-
gested by both the gamma amplitude and its correlation
strength to improved symptomatology when comparing
results from more circumscribed bipolar electrode record-
ings to that of the largest sampling area. Although all
channels showed changes in gamma power correlated with
decreased tic severity, the fluctuations were greatest in
channel four. This channel represented the largest sampling
of population activity because it had the largest spatial
sampling area (the greatest possible lead distribution,
across contacts 1–4) (see Fig. 6a).
The collective activity of neuronal ensembles gives rise to
neuronal oscillations, which reflect the specific temporal
coordination of the population. There is extensive evidence
that this coordinated activity (synchronized oscillations) is
associatedwith awide range of functions as part of the normal
communication found in healthy brain processes. Pathologi-
cal states of brain dysfunction are expressed as altered coor-
dination states, represented neurophysiologically as perverted
2 One patient was presented at 5 months.
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rhythms. Aberrant oscillations have been associated with a
variety of disorders and have become the focus of intense
examination over the last years (Llinas et al. 1999; Brown
2003; Uhlhaas and Singer 2006; Maling et al. 2012).
One theory which sparked the movement towards
understanding neurological and neuropsychiatric disorders
in terms of abnormal synchronization patterns is that of
thalamocortical dysrhythmia (TCD) (Llinas et al. 1999;
McCormick 1999). TCD suggests that the mechanism that
produces disorders from Parkinson’s disease to depression
is the same and that it is functionally based on the elec-
trophysiological properties of the thalamocortical loop. The
two main tenants of TCD are (1) a shift to persistent theta
oscillations and (2) large-scale coherence that unremit-
tingly restricts and alters the dynamic reorganization of the
brain. This widespread activity results in an ectopic gamma
that arises from ‘‘an edge effect’’.
So influential was this theory that it was purported to be
the mechanism underlying tic genesis in GTS by one of the
most renowned figures in the field (Leckman et al. 2006).
In the absence of any direct, electrophysiological record-
ings to the contrary, this hypothesis of hypersynchroniza-
tion was entirely plausible. In order to test the theory and
definitively determine its validity, similar analyses were
performed using the chronic LFP recordings of the
thalamus.
The first line of comparison was a determination of theta
behavior in GTS. To adhere to the most important char-
acteristic distinguishing theta rhythmicity, theta power
would have to be either consistently high, or increase with
increased severity of symptoms. Neither was the case. In
fact no consistent correlation was observed between the
theta band and changes in symptomatology, its behavior
seemed independent of such changes (Maling et al. 2012).
The second and perhaps most telling analysis was of
spectral power correlation plots. Using the nearly identical
algorithm described in the original paper, frequencies were
plotted to find the cross-frequency coherence between theta
and gamma power. Here the results were quite interesting.
Increased theta-gamma correlations were not linked to
greater dysfunctional state, but rather the contrary (un-
published results). They were observed to be increasing in
coherence in correlation with improving symptomatology.
However, similar to fluctuations purely in the gamma band,
the results were non-linear. Rather, the largest power
changes occurred when the greatest change in tic severity
occurred as indicated by a decrease inYGTSS scores. Thus,
it wasn’t the lowest score that showed the highest coher-
ence, but rather the greatest drop in score (D).
Additionally, dynamic patterning was observed in the
coherence matrix between frequencies which fluctuated
with behavioral state (personal observation). These alter-
ations in the coordination matrices of recorded ensembles
are a reflection of network activity and thus, some func-
tional parameter of information processing in the thalamus.
As there is a close correlation between aberrant oscillatory
activity and variation in the disease state (e.g. Parkinson’s
disease (aberrant beta) versus GTS (aberrant gamma)),
dynamic changes that occur in neuronal networks in
response to DBS therapy contribute specific information to
the possible pathological mechanism of impairment among
other things in the coherence matrix. The results of this
study, therefore, suggest that oscillations have a functional
role in the pathophysiology of GTS.
Conclusions, Discussion and Future Directions
There is at present no scientifically described category for
Gilles de la Tourette syndrome (Cavanna and Rickards
2013). While there is much contributory information
accounting for it, there is an enormous explanatory gap
between the descriptive definition presently available and a
true neurobiological understanding of it. Like other psy-
chiatric disorders, diagnosis is ‘‘restricted to subjective
symptoms and observable signs’’ (Insel and Cuthbert
2015). The rigorous application of behavioral, biological
and computational measures to the dysfunctional brain
states giving rise to GTS and other psychiatric disorders
will not only offer a more complete characterization of
them, but also provide firm, scientifically quantifiable cri-
terion for them. This lays the foundation for precision
medicine, where distinct aspects of underlying dysfunction
can be targeted to deliver consistently successful therapies
for optimized patient care.
Because definitive diagnostic tests are as of yet still
lacking, GTS is presently classified by the observation of
symptoms. As comorbidities can be exceedingly high (up
to 90 % in specialized clinics), in particular with OCD and
ADHD, it becomes nontrivial to establish the etiological
basis of the wide range of phenotypes observed in such
patients (Grados and Mathews 2009). The complex profile
regularly—and rightfully—attributed to these individuals
has led to the practical consideration of typing GTS. When
the typing includes OCD, three classes emerge: TS only,
TS ? OCD, and TS ? OCD ? ADHD. Of these, the first
and the last are considered authentically heritable. This is
particularly interesting—and confounding—when one
considers how intimately compulsions are related to tics;
and yet, it is the addition of ADHD that provides evidence
of a shared genetic foundation.
It has been suggested that GTS is a neuropsychiatric
spectrum disorder. While it shares many commonalities
with OCD and ADHD—and all three are disorders
exhibiting excessive activity—the strong asymmetries
between their profiles are a red flag. Of particular note is
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the extremely low comorbidity of OCD/ADHD with GTS.
This small percentage may represent where the true heri-
tability between these groups can be found, substantiating
the conclusions of the GWAS of GTS and OCD: that these
highly comorbid disorders have a complex genetic rela-
tionship but do not share a genetic architecture. This could
be expressed as similarities and differences in pathophys-
iological mechanisms and neural networks circuits. The
correlations and asymmetries observed in GTS comor-
bidities could be a staple for gene studies which go beyond
the simple phenotypic expression of observable traits.
Exploration of the genetic basis of certain endopheno-
types may be profitable (Gould and Gottesman 2006). GTS
presents with a broad range of phenotypes which may arise
from a heterogeneous genetic profile. Plausibly, the trans-
lation of such varied genetic expression is the variety of
structural and functional abnormalities detected in the
Tourette brain. Such a complex clinical and biological
picture is especially challenging for the discovery of risk-
conferring common genetic variants. It is unsurprising
then, that GWAS have thus far not reported any. A
promising method for addressing these issues is gene net-
work analysis. Analyses based on differential gene
expression with gene co-expression allow the identification
of relevant gene networks of the disease state to be dis-
tinguished. By examining co-regulated patterns of gene
expression, gene network analysis can link the translational
changes in the expression of gene clusters with clinical
reports of the observed endophenotypes.
GTS has been studied extensively using imaging and
other indirect techniques that have shown structural and
functional abnormalities in the contributors to the CBGTC
circuit. However, results of these studies are conflicting
and/or have not been replicated, in addition to being
inherently more circumstantial. Moving forward, these
studies would benefit from increased parameter control,
which includes behavioral states, therapeutic effects (such
as neuroleptics), and comorbidities.
Individuals with GTS necessarily suffer from abnormal
brain organization. As a self-limiting neurodevelopmental
disorder, examination of the alterations in the connectivity
dynamics of the CBGTC over the natural history of the dis-
order would reveal the dynamic spatiotemporal equilibrium
states of the network correlating with its dictated emergent
behavioral state. Perturbations in the balance of the anatomi-
cal and functional connections in the circuits of this ever-
important, delicately-poised yet robust network manifest as
the cognitive, motor, and/or limbic deficits in dysfunctional
disease states. Fluctuations in the coordinationmatrices of the
CBGTC network likely actualize as the biological basis of a
wide range of behaviors associated with the signs and
symptoms of various disorders including Parkinson’s disease,
Huntington’s disease, GTS, OCD, ADHD and others.
Intrinsic or extrinsic mechanisms, like plasticity or DBS,
may be employed to recalibrate the neuronal equilibrium of
network interactions (McIntyre et al. 2004; Babadi and
Abbott 2010; Maling et al. 2012; Hashemiyoon 2013). This
could be quantitatively measured by analysis of the chan-
ges in the activation of neuronal ensembles, such as indi-
cated by alteration in their levels of synchronization. Such
calculations directly address important questions about the
underlying mechanisms of GTS pathophysiology.
Aberrant oscillatory behavior has been suggested to
subserve various neuropsychiatric disorders and has been
reported in GTS (Llinas et al. 1999; Uhlhaas and Singer
2006; Maling et al. 2012). Changes in the synchronized
rhythms of specific frequency band activity (such as
gamma) are reflected as neurophysiological fluctuations
that could be correlated with alterations in motor and/or
behavioral impairment, measurable by a relevant clinical
metric (such as the YGTSS). DBS offers the unique
opportunity to take direct electrophysiological recordings
from the purported areas of dysfunction in neuropsychiatric
disorders in humans. By tracking specific neurobiological
changes in dysfunctional networks, potential biomarkers
for GTS could be revealed.
Unfortunately, there are precious few direct investiga-
tions of the dynamic changes in pathology in humans. To
date, there is only one longitudinal study reported in human
subjects to quantify the underlying neurophysiological
dynamics as correlated with therapeutic effect (Maling
et al. 2012). That study revealed changes in the synchro-
nization of gamma oscillations in the thalamic network of
GTS patients in correlation with changes in symptomatol-
ogy resulting from DBS therapy. Furthermore, changes in
theta/gamma coherence have been correlated with changes
in therapeutic benefit. The discovery of these neuromarkers
is non-trivial, both scientifically and clinically.
Linking observations from different methodologies
could provide some requisite quantifiable results. Demon-
strated here for the first time is a mechanism by which
alteration in the genetic domain generates a neuropatho-
physiological modification of network dynamics correlated
with tic expression in GTS. Combining results from genetic
network analyses revealing changes in interneuron-related
genes with results from the longitudinal DBS study indi-
cating changes in oscillatory synchronization illustrates a
translational effect from molecular mechanisms to network
neurophysiology which correlates with tic symptomatol-
ogy. The down-regulation of hundreds of interneuron-re-
lated genes affects the balance of excitation/inhibition
necessary for proper information processing in the brain.
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This imbalance in turn alters the structural and functional
organization of the ensembles giving rise to synchronized
oscillatory behavior. Such changes are expressed as an
increase or decrease in the coordinated activity of neuronal
ensembles which manifests as hyper- or hypo-synchronized
oscillations. Thus, results from a genetic study substantiate
the findings from a DBS investigation concluding that
hyposynchronization of oscillations are correlated with tic
expression. These combined approaches offer powerful
insights into tic genesis in GTS and the functional role of
oscillations in its dysfunction.
Studies in human subjects are especially important for
psychiatric disorders, such as GTS, which suffer from
insufficient animal models (Salgado and Sandner 2013).
Results from human investigations can be apparently and
swiftly applicable to the understanding and treatment of the
associated disorders, and effect the development of
improved therapeutic interventions.
Knowledge of biomarkers and their specific character-
istic involvement in the disease state are valuable for the
development of next-generation technologies such as
closed-loop stimulation. Patient care would greatly benefit
because of: (1) on-board improvements in target localiza-
tion intra-operatively, (2) tailored treatment postopera-
tively, and (3) objective therapeutic assessment of the
efficacy of stimulation parameters.
Further improvement of therapeutic strategies for patient
care will come from studies which expand their scope. In
order to elucidate the role of the various structures in the
complex network giving rise to GTS, simultaneous
recordings from subcortical networks concomitant with
cortical recordings are needed. The inclusion of modern
electrical neuroimaging methods with DBS studies is piv-
otal to a more comprehensive explanation of the mecha-
nisms subserving GTS (Michel and Murray 2012;
Hashemiyoon et al. 2016). Further investigations into
oscillations and their aberrations in the larger networks of
the CBGTC and brain are essential for understanding
causality, function and the regulation of information inte-
gration. Investigation of these networks on a patient-by-
patient basis using combined cortical-subcortical record-
ings delivers an improved estimation of the communication
between the circuit nodes for each individual and provides
a platform for personalized medicine.
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